Anrukinzumab, CAS [[910649-32-0]]

Produktübersicht

• Artikelname: Anrukinzumab, CAS [[910649-32-0]]
• Artikelnummer: TGM-T76906
• Hersteller Artikelnummer: T76906
• Alternativnummer: TGM-T76906-1MG,TGM-T76906-5MG,TGM-T76906-10MG,TGM-T76906-25MG,TGM-T76906-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: IMA-638

Produktbeschreibung

Anrukinzumab (IMA-638) is a humanized monoclonal antibody that specifically targets and neutralizes interleukin-13 (IL-13). Anrukinzumab has demonstrated significant anti-inflammatory effects in validated non-human primate models of disease, supporting its ongoing research for the treatment of ulcerative colitis (UC) and asthma.

Produkteigenschaften

• Reinheit: 97.00%
• CAS Nummer: [910649-32-0]
• Target-Kategorie: Interleukin|||IL Receptor